Citation: R. Paolini et al., Acute myocardial infarction during treatment with intravenous immunoglobulin for idiopathic thrombocytopenic purpura (ITP), AM J HEMAT, 65(2), 2000, pp. 177-178
Authors:
Lunazzi, L
Mazzanti, A
Casarini, D
De Lucchi, O
Fabris, F
Citation: L. Lunazzi et al., Conformational studies by dynamic NMR. 70. Stereomutations of homochiral dicarvone in solution and in the solid state, J ORG CHEM, 65(3), 2000, pp. 883-888
Authors:
Fabris, F
Ahmad, S
Cella, G
Jeske, WP
Walenga, JM
Fareed, J
Citation: F. Fabris et al., Pathophysiology of heparin-induced thrombocytopenia clinical and diagnostic implications - A review, ARCH PATH L, 124(11), 2000, pp. 1657-1666
Authors:
Paquette, LA
Fabris, F
Tae, JS
Gallucci, JC
Hofferberth, JE
Citation: La. Paquette et al., Catalytic ring-closing metathesis of doubly armed, bridged bicyclic sulfones. Evaluation of chain length and possible intramolecular SO2 group ligation to the ruthenium carbenoid, J AM CHEM S, 122(14), 2000, pp. 3391-3398
Authors:
Peters, K
Peters, EM
Leoni, L
Fabris, F
De Lucchi, O
Citation: K. Peters et al., Crystal structure of (1S,1 ' S,2S,2 ' S,5R,5R)-2,2 '-diisopropyl-5,5 '-dimethylbicyclohexyl-1,1-diol, [(CH3)C6H8OH(C3H7)](2), Z KRIST-NEW, 214(3), 1999, pp. 355-356
Authors:
Peters, K
Peters, EM
Leoni, L
Fabris, F
De Lucchi, O
Citation: K. Peters et al., Crystal structure of (3S,6R)-3-isopropyl-2-[(3R,6S)-6-isopropyl-3-methyl-1-cyclohexenyl]-6-methylcyclohexene, [C6H7(CH3)(C3H7)](2), Z KRIST-NEW, 214(2), 1999, pp. 271-272
Authors:
Randi, ML
Rossi, C
Fabris, F
Menapace, L
Girolami, A
Citation: Ml. Randi et al., Aspirin seems as effective as myelosuppressive agents in the prevention ofrethrombosis in essential thrombocythemia, CL APPL T-H, 5(2), 1999, pp. 131-135
Authors:
Fabris, F
Luzzatto, G
Sartori, MT
Zanella, I
Girolami, A
Citation: F. Fabris et al., A paradoxical side-effect of antiaggregating treatment with ticlopidine: the Moschowitz syndrome, HAEMATOLOG, 84(8), 1999, pp. 760-762
Citation: Ml. Randi et al., Leukemia and myelodysplasia in patients with essential thrombocythemia treated with cytotoxic agents, HAEMATOLOG, 84(11), 1999, pp. 1049-1050
Authors:
Galletti, F
Strazzullo, P
Capaldo, B
Carretta, R
Fabris, F
Ferrara, LA
Glorioso, N
Semplicini, A
Mancini, M
Citation: F. Galletti et al., Controlled study of the effect of angiotensin converting enzyme inhibitionversus calcium-entry blockade on insulin sensitivity in overweight hypertensive patients: Trandolapril Italian study (TRIS), J HYPERTENS, 17(3), 1999, pp. 439-445
Authors:
Mazzega, M
Fabris, F
Cossu, S
De Lucchi, O
Lucchini, V
Valle, G
Citation: M. Mazzega et al., Synthesis, atropoisomerism and chemistry of the dimers of R-(-)-carvone, R-(-)-hydrocarvone, 1R,5R-(+)-pinocarvone and other monoterpenic ketones, TETRAHEDRON, 55(14), 1999, pp. 4427-4440
Authors:
Fabris, F
De Lucchi, O
Delogu, G
Fabbri, D
Citation: F. Fabris et al., Condensation of chiral 1,3-oxazolidines with cathecol and 4,4 '-dibromobiphenol: New enantiopure polydentate ligands with C-2-symmetry, SYN COMMUN, 29(11), 1999, pp. 2007-2012
Authors:
Bo, M
Fiandra, U
Fonte, G
Bobbio, M
Fabris, F
Citation: M. Bo et al., Cholesterol and long-term mortality after acute myocardial infarction in elderly patients, AGE AGEING, 28(3), 1999, pp. 313-315
Authors:
Peters, K
Peters, EM
Fabris, F
De Lucchi, O
Citation: K. Peters et al., Crystal structure of (1R,2S,4R)-2-(2-hydroxy-3-(2-hydroxyphenyl)benzyl)-1,7,7-trimethyl-bicyclo[2.2.1]heptan-2-ol, C23H28O3, Z KRIST-NEW, 213(1), 1998, pp. 107-108
Authors:
Peters, K
Peters, EM
Fabris, F
Cossu, S
De Lucchi, O
Citation: K. Peters et al., Crystal structure of (1R,2S)-2-(methyl((E)-2-(phenylsulphonyl)-1-ethenyl)-amino)-1-phenylpropan-1-ol, C18H21NO3S, Z KRIST-NEW, 213(1), 1998, pp. 109-110
Authors:
Peters, K
Peters, EM
Olioso, B
De Lucchi, O
Fabris, F
Citation: K. Peters et al., Crystal structure of 2-iodo-dinaphtho[2,1-h : 1,2-l]-7,12-dioxaspiro[5.6]dodecane, C26H21O2I, Z KRIST-NEW, 213(1), 1998, pp. 111-113